AstraZeneca PLC Return On Assets Over Time
AZN Stock | USD 76.35 0.55 0.73% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out AstraZeneca PLC Performance and AstraZeneca PLC Correlation. AstraZeneca |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.207 | Dividend Share 2.9 | Earnings Share 2.02 | Revenue Per Share 2.5512 | Quarterly Revenue Growth 0.165 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Return On Assets Analysis
Compare AstraZeneca PLC ADR and related stocks such as Shuttle Pharmaceuticals, Lifecore Biomedical, and Journey Medical Corp Return On Assets Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHPH | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.5538) | (1.846) | (0.3582) | (1.1077) | (1.16) |
LFCR | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.4005) | (0.0138) | (0.0145) |
DERM | (0.1789) | (0.1789) | (0.1789) | (0.1789) | (0.1789) | (0.3533) | (0.285) | (0.5408) | (0.6434) | 0.1071 | 0.1018 | (0.4522) | (0.2817) | (0.0501) | (0.0526) |
LSDI | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (25.1162) | (1.279) | (1.334) | (1.0239) | (0.92) | (0.97) |
ORGO | (7.0E-4) | (7.0E-4) | (7.0E-4) | (7.0E-4) | (7.0E-4) | (7.0E-4) | (7.0E-4) | (0.0067) | (0.3961) | (0.1833) | 0.0585 | 0.2125 | 0.0346 | 0.0107 | 0.0113 |
CYTH | (0.9258) | (0.035) | 0.0283 | 0.0735 | (0.1121) | (0.5363) | (2.2605) | (1.8352) | (1.4583) | (1.8658) | (0.6289) | (0.7328) | (3.6249) | (1.514) | (1.44) |
SXTC | 0.2182 | 0.2182 | 0.2182 | 0.2182 | 0.2182 | 0.2182 | 0.2182 | 0.1551 | 0.0881 | (0.474) | (0.0795) | (0.171) | (0.2008) | (0.23) | (0.22) |
AstraZeneca PLC ADR and related stocks such as Shuttle Pharmaceuticals, Lifecore Biomedical, and Journey Medical Corp Return On Assets description
A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.My Equities
My Current Equities and Potential Positions
AstraZeneca PLC ADR | AZN |
CompulsionFama & French Classification | |
Location | United Kingdom |
Exchange | NASDAQ Exchange |
USD 76.35
Check out AstraZeneca PLC Performance and AstraZeneca PLC Correlation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.